Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 1 AL 15

Discriminative self-representation sparse regression for neuroimaging-based alzheimer's disease diagnosis

Zhu X, Suk HI, Lee SW, Shen D.

Brain Imaging Behav. 2019 Feb;13(1):27-40. doi: 10.1007/s11682-017-9731-x.

Advances in the Prediction of Protein Aggregation Propensity

Pallarés I, Ventura S.

Curr Med Chem. 2019;26(21):3911-3920. doi: 10.2174/0929867324666170705121754.

NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease

Ju Hwang C, Choi DY, Park MH, Hong JT.

CNS Neurol Disord Drug Targets. 2019;18(1):3-10. doi: 10.2174/1871527316666170807130011.

A Scoping Review of Physical Performance Outcome Measures Used in Exercise Interventions for Older Adults With Alzheimer Disease and Related Dementias

McGough EL, Lin SY, Belza B, Becofsky KM, Jones DL, Liu M, Wilcox S, Logsdon RG.

J Geriatr Phys Ther. 2019 Jan/Mar;42(1):28-47. doi: 10.1519/JPT.0000000000000159.

Neuroprotective Effects of Flavonoid Compounds on Neuronal Death Associated to Alzheimer's Disease

Sureda A, Capó X, Tejada S.

Curr Med Chem. 2019;26(27):5124-5136. doi: 10.2174/0929867325666171226103237.

Aerobic Exercise Sustains Performance of Instrumental Activities of Daily Living in Early-Stage Alzheimer Disease

Vidoni ED, Perales J, Alshehri M, Giles AM, Siengsukon CF, Burns JM.

J Geriatr Phys Ther. 2019 Jul/Sep;42(3):E129-E134. doi: 10.1519/JPT.0000000000000172.

Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review

da Costa IM, Freire MAM, de Paiva Cavalcanti JRL, de Araújo DP, Norrara B, Moreira Rosa IMM, de Azevedo EP, do Rego ACM, Filho IA, Guzen FP.

Curr Neuropharmacol. 2019;17(5):406-421. doi: 10.2174/0929867325666180117112610.

Therapeutic Potential of Multifunctional Tacrine Analogues

Przybyłowska M, Kowalski S, Dzierzbicka K, Inkielewicz-Stepniak I.

Curr Neuropharmacol. 2019;17(5):472-490. doi: 10.2174/1570159X16666180412091908.

Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview

Baheti K, Kale M.

Curr Drug Discov Technol. 2019;16(1):66-73. doi: 10.2174/1570163815666180417120833.

Viral Induced Oxidative and Inflammatory Response in Alzheimer's Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach

Talwar P, Gupta R, Kushwaha S, Agarwal R, Saso L, Kukreti S, Kukreti R.

Curr Neuropharmacol. 2019;17(4):352-365. doi: 10.2174/1570159X16666180419124508.

Drugs for Targeted Therapies of Alzheimer's Disease

Tam C, Wong JH, Ng TB, Tsui SKW, Zuo T.

Curr Med Chem. 2019;26(2):335-359. doi: 10.2174/0929867325666180430150940.

Aporphines and Alzheimer's Disease: Towards a Medical Approach Facing the Future

Nabavi SM, Uriarte E, Rastrelli L, Sobarzo-Sánchez E.

Curr Med Chem. 2019;26(18):3253-3259. doi: 10.2174/0929867325666180514102933.

A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease

Korabecny J, Spilovska K, Mezeiova E, Benek O, Juza R, Kaping D, Soukup O.

Curr Med Chem. 2019;26(30):5625-5648. doi: 10.2174/0929867325666180517094023.

Dantrolene : From Malignant Hyperthermia to Alzheimer's Disease

Shi Y, Wang Y, Wei H.

CNS Neurol Disord Drug Targets. 2019;18(9):668-676. doi: 10.2174/1871527317666180619162649.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias